These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 10709119

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial.
    Brown MS, Keith JF.
    Pediatrics; 1999 Aug; 104(2 Pt 1):210-5. PubMed ID: 10428996
    [Abstract] [Full Text] [Related]

  • 64. [Prevention of anemia of prematurity].
    Atanassova V, Ionov M, Rosmanova R, Simov V.
    Akush Ginekol (Sofiia); 2009 Aug; 48(6):23-6. PubMed ID: 20225493
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis.
    Brugnara C, Colella GM, Cremins J, Langley RC, Schneider TJ, Rutherford CJ, Goldberg MA.
    J Lab Clin Med; 1994 May; 123(5):660-7. PubMed ID: 8195672
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Enteral administration of recombinant erythropoietin to preterm infants.
    Britton JR, Christensen RD.
    J Perinatol; 1995 May; 15(4):281-3. PubMed ID: 8558334
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Double blind trial of recombinant human erythropoietin in preterm infants.
    Emmerson AJ, Coles HJ, Stern CM, Pearson TC.
    Arch Dis Child; 1993 Mar; 68(3 Spec No):291-6. PubMed ID: 8466265
    [Abstract] [Full Text] [Related]

  • 73. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A.
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Financial impact of the introduction of erythropoietin in the treatment of anemia of premature infants in Israel.
    Dollberg S, Mimouni FB.
    Isr Med Assoc J; 1999 Oct; 1(2):86-8. PubMed ID: 10731302
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Recombinant human erythropoietin: has treatment reached its full potential?
    Fishbane S.
    Semin Dial; 2006 Oct; 19(1):1-4. PubMed ID: 16423172
    [Abstract] [Full Text] [Related]

  • 78. High Prevalence of Iron Deficiency Despite Standardized High-Dose Iron Supplementation During Recombinant Erythropoietin Therapy in Extremely Low Gestational Age Newborns.
    Siddappa AM, Olson RM, Spector M, Northrop E, Zamora T, Brearley AM, Georgieff MK, Rao R.
    J Pediatr; 2020 Jul; 222():98-105.e3. PubMed ID: 32418819
    [Abstract] [Full Text] [Related]

  • 79. Human immunodeficiency virus infection, anemia, and survival.
    Moore RD.
    Clin Infect Dis; 1999 Jul; 29(1):44-9. PubMed ID: 10433563
    [Abstract] [Full Text] [Related]

  • 80. Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants.
    Khatami SF, Mamouri G, Torkaman M.
    Indian J Pediatr; 2008 Dec; 75(12):1227-30. PubMed ID: 19057854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.